Addison’s disease treatment market is growing with advancements in hormone replacement therapies, including glucocorticoids and mineralocorticoids, ensuring better disease management by 2035.

Cena Hermus, 7, was two years old when she was diagnosed with a rare, life-threatening disorder that causes severe obesity.

Addison’s disease is a rare condition in which the adrenal glands do not produce enough of the hormones cortisol and ...

On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...